The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

N/ACompletedNCT02042638

Gulhane School of Medicine16 enrolled

Overview

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Idiopathic Hypogonadotropic Hypogonadism

Interventions

hCG 1500 IU three times a weekDRUG

Pregnyl (hCG) ampule 1500 IU/three times a weekDRUG

Eligibility

Sex: MALEMin age: 16 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: Serum testosterone concentration \< 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, - Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies \-

Locations (1)

Gulhane School of Medicine Dep. of Endocrinology and Metabolism

Ankara, Turkey (Türkiye)

Outcomes

Primary Outcomes

HDL after hCG treatment

2011-2013

Time frame: 2011-2013

LDL levels after hCG treatment

Time frame: 2011-2013

total cholesterole levels after hCG treatment

Time frame: 2011-2013

Secondary Outcomes

Body fat ratio after hCG treatment

Time frame: 2011-2013

hsCRP levels after hCG treatment

Time frame: 2011-2013

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.